IP Library Granted Patent US 11,000,556
Granted Patent B2
US 11,000,556 · App. 16/669,596 · Granted May 11, 2021

Compositions and methods for the treatment of allergy

Inventors: Rose L. Szabady (Cambridge, MA); Bernat Olle (Cambridge, MA); Bruce Roberts (Sudbury, MA)
Assignee: Vedanta Biosciences, Inc.
A61K35/74A61K9/0053A61K9/19A61K9/48A61K31/00A61K35/741A61P37/08A61K9/0056A61K9/4866
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,000,556
App. No.
16/669,596
Granted
May 11, 2021
Kind
B2
Abstract

Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.

Claims (30)

1. A method of treating a food allergy, comprising orally administering to a subject in need thereof a therapeutically effective amount of a composition comprising a purified bacterial mixture comprising 7 bacterial strains each comprising one of 16S rDNA sequences having at least 99.5% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, or SEQ ID NO:8; wherein there is 1 strain comprising each of the 16S rDNA sequences having at least 99.5% sequence identity to SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8.

2. The method of claim 1 , wherein the subject is administered an antibiotic prior to administration of the composition.

3. The method of claim 2 , wherein the antibiotic is vancomycin.

4. The method of claim 1 , wherein the food allergy is selected from the group consisting of a nut allergy, a fish allergy, a wheat allergy, a milk allergy, a peanut allergy, a tree nut allergy, a shellfish allergy, a soy allergy, a seed allergy, a sesame seed allergy, and an egg allergy.

5. The method of claim 1 , wherein the food allergy is a peanut allergy.

6. The method of claim 1 , wherein one or more of the bacterial strains are in spore form.

7. The method of claim 1 , wherein one or more of the bacterial strains are lyophilized.

8. The method of claim 1 , wherein all of the bacterial strains are lyophilized.

9. The method of claim 1 , wherein one or more of the bacterial strains are spray-dried.

10. The method of claim 1 , wherein all of the bacterial strains are spray-dried.

11. The method of claim 1 , wherein the bacterial strains originate from more than one human donor.

12. The method of claim 1 , wherein the composition is in the form of a capsule.

13. The method of claim 1 , wherein the composition further comprises one or more enteric polymers.

14. The method of claim 1 , wherein the composition further comprises one or more adjuvants.

15. The method of claim 3 , wherein vancomycin is administered in 4 doses of 125 mg vancomycin per day for 5 days.

16. A method of treating a food allergy, comprising orally administering to a subject in need thereof a therapeutically effective amount of a composition comprising a purified bacterial mixture comprising 7 bacterial strains selected from the group consisting of Clostridium bolteae, Anaerotruncis colihominis, Eubacterium fissicatena, Clostridium symbiosum, Blautia producta, Dorea longicatena, Clostridium innocuum , and Flavinofractor plautii.

17. The method of claim 16 , wherein the subject is administered an antibiotic prior to administration of the composition.

18. The method of claim 17 , wherein the antibiotic is vancomycin.

19. The method of claim 16 , wherein the food allergy is selected from the group consisting of a nut allergy, a fish allergy, a wheat allergy, a milk allergy, a peanut allergy, a tree nut allergy, a shellfish allergy, a soy allergy, a seed allergy, a sesame seed allergy, and an egg allergy.

20. The method of claim 16 , wherein the food allergy is a peanut allergy.

21. The method of claim 16 , wherein one or more of the bacterial strains are in spore form.

22. The method of claim 16 , wherein one or more of the bacterial strains are lyophilized.

23. The method of claim 16 , wherein all of the bacterial strains are lyophilized.

24. The method of claim 16 , wherein one or more of the bacterial strains are spray-dried.

25. The method of claim 16 , wherein all of the bacterial strains are spray-dried.

26. The method of claim 16 , wherein the bacterial strains originate from more than one human donor.

27. The method of claim 16 , wherein the composition is in the form of a capsule.

28. The method of claim 16 , wherein the composition further comprises one or more enteric polymers.

29. The method of claim 16 , wherein the composition further comprises one or more adjuvants.

30. The method of claim 18 , wherein vancomycin is administered in 4 doses of 125 mg vancomycin per day for 5 days.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2023
From: OXFORD FINANCE LLC
To: VEDANTA BIOSCIENCES, INC.
Reel/Frame 063440/0569 →
SECURITY INTEREST Recorded Apr 21, 2023
From: VEDANTA BIOSCIENCES, INC.
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE
Reel/Frame 063406/0052 →
SECURITY INTEREST Recorded Dec 12, 2022
From: VEDANTA BIOSCIENCES, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062115/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2020
From: SZABADY, ROSE L.; OLLE, BERNAT; ROBERTS, BRUCE
To: VEDANTA BIOSCIENCES, INC.
Reel/Frame 053339/0731 →
Continuity (6)
Continuation 16229288 · Dec 21, 2018
Continuation PCTUS2018060187 · Nov 9, 2018
Provisional Application 62721786 · Aug 23, 2018
Provisional Application 62637355 · Mar 1, 2018
Provisional Application 62583777 · Nov 9, 2017
Related Publication 20200171101A1 · Jun 4, 2020
Cited By (4)
US 12,214,003 US 12,409,196 US 12,502,411 US 12,582,679